Topic: Somaxon Pharmaceuticals Inc.

Somaxon, Procter & Gamble agree to co-promote new insomnia drug SilenorSomaxon Pharmaceuticals Inc. will team with Procter & Gamble Co. to co-promote the insomnia treatment Silenor to thousands of doctors and pharmacies. The companies will combine sales forces to target 35,000 of ...
Somaxon to sell 4 million shares to raise funds for marketing insomnia drug SilenorJust days after receiving Food and Drug Administration approval for Silenor, biotech company Somaxon Pharmaceuticals Inc. made plans to sell 4 million shares to fund marketing of the insomnia ...